Skip to main content
. 2020 Nov 10;19:190. doi: 10.1186/s12933-020-01164-8

Fig. 2.

Fig. 2

LDL-c levels in the overall population stratified by cholesterol lowering therapy and by ESC/EAS risk categories. For each subgroup of patients, we show numbers and percentages in the various LDL-c target range